Skip to content
2000
Volume 24, Issue 4
  • ISSN: 1871-5265
  • E-ISSN: 2212-3989

Abstract

Monkeypox is a viral disease; its outbreak was recently declared a global emergency by the World Health Organization. For the first time, a monkeypox virus (MPXV)-infected patient was found in India. Various researchers back-to-back tried to find the solution to this health emergency just after COVID-19. In this review, we discuss the current outbreak status of India, its transmission, virulence factors, symptoms, treatment, and the preventive guidelines generated by the Indian Health Ministry. We found that monkeypox virus (MPXV) disease is different from smallpox, and the age group between 30-40 years old is more prone to MPXV disease. We also found that, besides homosexuals, gays, bisexuals, and non-vegetarians, it also affects normal straight men and women who have no history of travel. Close contact should be avoided from rats, monkeys and sick people who are affected by monkeypox. To date, there are no monkeypox drugs, but Tecovirimat is more effective than other drugs that are used for other viral diseases like smallpox. Therefore, we need to develop an effective antiviral agent against the virulence factor of MXPV.

Loading

Article metrics loading...

/content/journals/iddt/10.2174/0118715265258451231214063506
2024-06-01
2025-05-04
Loading full text...

Full text loading...

/content/journals/iddt/10.2174/0118715265258451231214063506
Loading

  • Article Type:
    Review Article
Keyword(s): Monkeypox; MPXV; symptom; transmission; treatment; virulence factor; virus
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test